Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to -$9.6 million.

  • Jaguar Health's Income from Continuing Operations rose 372.22% to -$9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.0 million, marking a year-over-year decrease of 707.61%. This contributed to the annual value of -$39.3 million for FY2024, which is 632.44% up from last year.
  • Latest data reveals that Jaguar Health reported Income from Continuing Operations of -$9.6 million as of Q3 2025, which was up 372.22% from -$10.6 million recorded in Q2 2025.
  • Over the past 5 years, Jaguar Health's Income from Continuing Operations peaked at -$7.9 million during Q3 2023, and registered a low of -$18.2 million during Q1 2022.
  • For the 5-year period, Jaguar Health's Income from Continuing Operations averaged around -$11.2 million, with its median value being -$10.6 million (2025).
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first plummeted by 6327.97% in 2021, then soared by 4250.59% in 2022.
  • Quarter analysis of 5 years shows Jaguar Health's Income from Continuing Operations stood at -$14.3 million in 2021, then soared by 42.51% to -$8.2 million in 2022, then fell by 13.08% to -$9.3 million in 2023, then decreased by 9.94% to -$10.2 million in 2024, then grew by 5.73% to -$9.6 million in 2025.
  • Its Income from Continuing Operations stands at -$9.6 million for Q3 2025, versus -$10.6 million for Q2 2025 and -$10.6 million for Q1 2025.